FINHUB Insights

MRK · Q2 FY25 · Apr 1 – Jun 30, 2025

Merck & Q2 FY25: where the revenue came from and where it went

Merck & Q2 FY25: revenue $15.8B (−2% year over year). Net profit $4.4B. Largest cohort US $8.8B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2025
Reported
Aug 5, 2025 10-Q
Sankey diagram of Merck &'s income statement for Q2 FY25: revenue of $15.8 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$15.8B −2% year over year
Gross profit$12.2B 77% margin
Operating profit$5B 32% margin
Net profit$4.4B 28% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
ItemValueShare of revenueYear over year
Revenue 15.8 100% −2%
US 8.8 56% +12%
EMEA 3.7 23% +4%
Latin America 0.9 6% +0%
Asia Pacific 0.8 5% +5%
JP 0.6 4% −9%
Other Countries 0.6 4% −3%
CN 0.4 3% −75%
Cost of revenue−3.623%
Gross profit12.277% margin+1pp
Research & development−4.126%+4pp
SG&A−2.617%+0pp
Other−0.64%+0pp
Operating profit532% margin+0pp
Tax−0.6
Net profit4.428%−6pp
Filing on EDGAR More quarters of MRK

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters